CH494573A - Nouvelle composition cosmétique - Google Patents
Nouvelle composition cosmétiqueInfo
- Publication number
- CH494573A CH494573A CH261268A CH261268A CH494573A CH 494573 A CH494573 A CH 494573A CH 261268 A CH261268 A CH 261268A CH 261268 A CH261268 A CH 261268A CH 494573 A CH494573 A CH 494573A
- Authority
- CH
- Switzerland
- Prior art keywords
- skin
- elastolytic
- sep
- compound
- elastin
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 230000003246 elastolytic effect Effects 0.000 title claims abstract description 11
- 230000001153 anti-wrinkle effect Effects 0.000 title abstract description 3
- 150000001875 compounds Chemical class 0.000 claims description 15
- 102000016942 Elastin Human genes 0.000 claims description 9
- 108010014258 Elastin Proteins 0.000 claims description 9
- 229920002549 elastin Polymers 0.000 claims description 9
- 239000002537 cosmetic Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 108010044091 Globulins Proteins 0.000 claims description 2
- 102000006395 Globulins Human genes 0.000 claims description 2
- 238000000862 absorption spectrum Methods 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims description 2
- 108010074605 gamma-Globulins Proteins 0.000 claims description 2
- 230000005012 migration Effects 0.000 claims description 2
- 238000013508 migration Methods 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 6
- 238000001556 precipitation Methods 0.000 abstract description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract description 4
- 230000003796 beauty Effects 0.000 abstract description 4
- 230000032683 aging Effects 0.000 abstract description 3
- 210000000496 pancreas Anatomy 0.000 abstract description 3
- 102000001621 Mucoproteins Human genes 0.000 abstract description 2
- 108010093825 Mucoproteins Proteins 0.000 abstract description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 abstract description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 abstract description 2
- 235000011130 ammonium sulphate Nutrition 0.000 abstract description 2
- 238000000502 dialysis Methods 0.000 abstract description 2
- 239000006210 lotion Substances 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract description 2
- 102000004190 Enzymes Human genes 0.000 abstract 2
- 108090000790 Enzymes Proteins 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- 239000008351 acetate buffer Substances 0.000 abstract 1
- 239000008278 cosmetic cream Substances 0.000 abstract 1
- 229950010604 pancreas powder Drugs 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 8
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 210000004177 elastic tissue Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108010077465 Tropocollagen Proteins 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000007247 enzymatic mechanism Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- -1 paraffins Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940068917 polyethylene glycols Drugs 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR97731A FR1523250A (fr) | 1967-03-07 | 1967-03-07 | Compositions cosmétiques anti-rides |
FR97730 | 1967-03-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH494573A true CH494573A (fr) | 1970-08-15 |
Family
ID=26174873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH261268A CH494573A (fr) | 1967-03-07 | 1968-02-23 | Nouvelle composition cosmétique |
Country Status (8)
Country | Link |
---|---|
JP (1) | JPS4948517B1 (en。) |
BE (1) | BE711231A (en。) |
CH (1) | CH494573A (en。) |
DE (1) | DE1667890C3 (en。) |
FR (2) | FR1523250A (en。) |
GB (1) | GB1171078A (en。) |
LU (1) | LU55547A1 (en。) |
NL (1) | NL6803151A (en。) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU71110A1 (en。) * | 1974-10-15 | 1976-11-11 | ||
JPS5219720U (en。) * | 1975-07-31 | 1977-02-12 | ||
JPS5287024U (en。) * | 1975-12-24 | 1977-06-29 | ||
FR2369844A1 (fr) * | 1976-11-05 | 1978-06-02 | Montenegro Marina De | Produits de beaute a base de ptyaline, pour les soins de la peau |
JPS611612A (ja) * | 1984-06-14 | 1986-01-07 | Eisai Co Ltd | エラスタ−ゼ養毛剤 |
-
0
- FR FR250D patent/FR250F/fr active Active
-
1967
- 1967-03-07 FR FR97731A patent/FR1523250A/fr not_active Expired
-
1968
- 1968-02-23 CH CH261268A patent/CH494573A/fr not_active IP Right Cessation
- 1968-02-23 BE BE711231D patent/BE711231A/xx not_active IP Right Cessation
- 1968-02-23 LU LU55547D patent/LU55547A1/xx unknown
- 1968-03-05 GB GB1072368A patent/GB1171078A/en not_active Expired
- 1968-03-06 NL NL6803151A patent/NL6803151A/xx unknown
- 1968-03-07 JP JP43014595A patent/JPS4948517B1/ja active Pending
- 1968-03-07 DE DE19681667890 patent/DE1667890C3/de not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE1667890B2 (de) | 1973-03-08 |
GB1171078A (en) | 1969-11-19 |
FR250F (en。) | |
NL6803151A (en。) | 1968-09-09 |
LU55547A1 (en。) | 1968-05-03 |
DE1667890C3 (de) | 1973-10-11 |
BE711231A (en。) | 1968-07-01 |
JPS4948517B1 (en。) | 1974-12-21 |
FR1523250A (fr) | 1968-05-03 |
DE1667890A1 (de) | 1972-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1112057B1 (fr) | Utilisation cosmetique ou dermapharmaceutique de peptides pour la cicatrisation, l'hydratation et l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution) | |
FR2911779A1 (fr) | Composition contenant un extrait d'ambre | |
FR2826011A1 (fr) | Nouveaux derives de la 7-oxo-dhea et utilisation cosmetique | |
FR3029782A1 (fr) | Composes peptidiques, compositions les comprenant et utilisations notamment cosmetiques | |
FR2802425A1 (fr) | Utilisation d'un extrait d'au moins un vegetal de la famille des ericaceae comme agent anti-glycation | |
EP2675825B1 (fr) | Nouveaux peptides activateurs de la synthese des proteines de la matrice extracellulaire et compositions cosmetiques les comprenant | |
FR2740331A1 (fr) | Nouvelles compositions cosmetiques pour le traitement des cheveux et du cuir chevelu | |
CH494573A (fr) | Nouvelle composition cosmétique | |
FR2770228A1 (fr) | Procede d'obtention d'oligomeres de proanthocyanidines par biofermentation et leur utilisation dans des compositions cosmetiques, dietetiques, pharmaceutiques, chimiques et alimentaires | |
FR2971711A1 (fr) | Composition cosmetique comprenant un extrait de petit epeautre en tant qu'agent activateur de la synthese des proteines de la matrice extracellulaire | |
FR2837386A1 (fr) | Compositions a usage cosmetique ou dermopharmaceutique contenant une association de deux extraits d'algues obtenus a partir d'ascophyllum nodosum et d'halopteris scoparia (:stypocaulon scoparium) | |
FR2999079A1 (fr) | Utilisation cosmetique d'un extrait de germe de caroube en tant qu'agent actif amincissant | |
FR2854799A1 (fr) | Utilisation d'extraits des graines de plantes appartenant au genre adenanthera pour la fabrication de preparations cosmetiques et/ou dermatologiques | |
EP2086564A1 (fr) | Composition pharmaceutique et/ou cosmetique contenant des peptides | |
BR112019023568A2 (pt) | Conjugado de isotretinoína e peptídeo | |
WO2012153015A1 (fr) | Nouveaux peptides modulateurs de la proteine trf2 et compositions les comprenant | |
FR2973381A1 (fr) | Nouveaux composes oligosaccharides et leur utilisation cosmetique | |
FR2938765A1 (fr) | Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis vinifera l.) en tant que principe actif activateur des proteines sirt | |
WO2008015344A2 (fr) | Composition dermatologique et/ou cosmetique contenant des polypeptides ou des peptides issus de la proteine slc24a5 | |
JP4002760B2 (ja) | 皮膚外用剤 | |
TWI873241B (zh) | 用於化妝品及醫藥之胜肽及組成物 | |
FR2850868A1 (fr) | Utilisation d'un extrait de champignon mycorrhiza pour la preparation d'agents cosmetiques et/ou dermopharmaceutiques | |
FR2904546A1 (fr) | Utilisation d'un extrait de riz en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes | |
FR2904543A1 (fr) | Utilisation d'un extrait de mais en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes | |
WO2007003768A2 (fr) | Utilisation d'un extrait de l'espece trigonella foenum graecum dans une composition cosmetique ou pharmaceutique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |